$3 a month generic semaglutide could change the math for millions
Posted by weekendnate in Weight Loss & Metabolic - 7 points, 6 comments.
Guardian piece on a study showing semaglutide could be manufactured for around three bucks a month in 160 lower and middle income countries. The math isn't surprising if you've seen what API costs look like in India and China, but seeing it spelled out in a peer reviewed model still hits different.
What gets me is the gap between that production cost and what people in the US are paying out of pocket, even with the recent pricing moves. If a month of therapy can be made for the price of a fast food lunch, the current US pricing structure starts to look more like a policy choice than a market outcome. The study also doesn't really touch on cold chain logistics or pen device costs, which is where a lot of the real world expense hides.
Is anyone here paying out of pocket for branded still, or has the generics situation in your country actually moved the needle yet?
Comments
- nightmarcus: I stopped paying for the brand stuff a while ago because the cost was just insane imo. I switched to a research route for my own weight loss and it seemed to work just as well for me, but the quality can be a real gamble when you aren't getting a pharmacy label. I track my fasting glucose and HRV to see if anything is off, and so far my numbers have stayed steady, though it could just be placebo or a good batch. The price gap is wild, but like you said, the cold chain is the real killer since th
- leah_vo2max: The cold chain thing is huge, people sleep on that. I've seen too many posts where someone's vial arrived cloudy or the solution looked off and they still used it. What are you tracking for HRV specifically, like overnight with a ring or chest strap? I use an ora ring but my fasting glucose i just poke once a week on an empty stomach, wondering if that's enough resolution to catch something off.
- grinder265: The cold chain thing is way underestimated by most people doing research route stuff. Even if the molecule itself survives a hot truck, the degradation products are a different animal. Not trying to scare you since your numbers are tracking fine, but if you ever do switch suppliers I'd want labs before and after, not just HRV and glucose as your only benchmarks. Those two can stay normal even with some sketchy stuff going on underneath.
- weekendnate: Fair point on the degradation angle, that's the part that bugs me too. I've been lucky with my current source but I've been guilty of leaning too hard on the convenient numbers. Adding a lipid panel and liver markers to my next round of bloodwork, probably throw in a baseline hsCRP while I'm at it. If something funky shows up in the degradation products I want to catch it before HRV or glucose starts waving a flag.
- weekendnate: Yeah cold chain is the part nobody wants to fund, and it's where a lot of the "cheap generic" promises quietly fall apart in practice. I'm using an Oura ring for nightly HRV and sleep, then a quarterly fasting panel for lipids, A1C, and a CMP. Weekly fingersticks felt like noise to me, the trend over months is what I care about. If something feels off day to day, I just log it in a note and check back against the ring data later.
- weekendnate: Appreciate you sharing the glucose and HRV tracking, that's exactly the kind of self-monitoring that makes it a real experiment instead of a coin flip. The hot delivery truck point is the one that worries me most too, because even a perfectly dosed vial is worthless if the peptide is denatured by the time it lands. I still pay out of pocket here, so I'm watching the UK generic rollout closely to see if pricing actually drops or if the pens keep it pinned.
Community discussion - research and educational context only. Not medical advice.